Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaspreet Toor

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Parasites & Vectors|November 18, 2020
The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?Klodeta Kura, Robert J Hardwick, James E Truscott, et al.
Infectious Disease Modelling|March 5, 2021
SCHISTOX: An individual based model for the epidemiology and control of schistosomiasisMatthew Graham, Diepreye Ayabina, Tim Cd Lucas, et al.
The Lancet. Global Health|October 14, 2022
Evaluating and mitigating the potential indirect effect of COVID-19 on control programmes for seven neglected tropical diseases: a modelling studyAnna Borlase, Epke A Le Rutte, Soledad Castaño, et al.
Vaccine|May 19, 2020
Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administrationKlodeta Kura, Benjamin S Collyer, Jaspreet Toor, et al.
BMJ Global Health|August 13, 2021
Are current preventive chemotherapy strategies for controlling and eliminating neglected tropical diseases cost-effective?Hugo C Turner, Wilma A Stolk, Anthony W Solomon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2018
Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?Jaspreet Toor, Ramzi Alsallaq, James E Truscott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2018
Investigating the Effectiveness of Current and Modified World Health Organization Guidelines for the Control of Soil-Transmitted Helminth InfectionsSam H Farrell, Luc E Coffeng, James E Truscott, et al.
The Journal of Infectious Diseases|December 13, 2019
Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?Jaspreet Toor, David Rollinson, Hugo C Turner, et al.
Parasites & Vectors|September 17, 2019
Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmissionJaspreet Toor, James E Truscott, Marleen Werkman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2018
Valuing the Unpaid Contribution of Community Health Volunteers to Mass Drug Administration ProgramsHugo C Turner, Jaspreet Toor, Alison A Bettis, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Parasites & Vectors|November 18, 2020
The impact of mass drug administration on Schistosoma haematobium infection: what is required to achieve morbidity control and elimination?Klodeta Kura, Robert J Hardwick, James E Truscott, et al.
Infectious Disease Modelling|March 5, 2021
SCHISTOX: An individual based model for the epidemiology and control of schistosomiasisMatthew Graham, Diepreye Ayabina, Tim Cd Lucas, et al.
The Lancet. Global Health|October 14, 2022
Evaluating and mitigating the potential indirect effect of COVID-19 on control programmes for seven neglected tropical diseases: a modelling studyAnna Borlase, Epke A Le Rutte, Soledad Castaño, et al.
Vaccine|May 19, 2020
Policy implications of the potential use of a novel vaccine to prevent infection with Schistosoma mansoni with or without mass drug administrationKlodeta Kura, Benjamin S Collyer, Jaspreet Toor, et al.
BMJ Global Health|August 13, 2021
Are current preventive chemotherapy strategies for controlling and eliminating neglected tropical diseases cost-effective?Hugo C Turner, Wilma A Stolk, Anthony W Solomon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2018
Are We on Our Way to Achieving the 2020 Goals for Schistosomiasis Morbidity Control Using Current World Health Organization Guidelines?Jaspreet Toor, Ramzi Alsallaq, James E Truscott, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 4, 2018
Investigating the Effectiveness of Current and Modified World Health Organization Guidelines for the Control of Soil-Transmitted Helminth InfectionsSam H Farrell, Luc E Coffeng, James E Truscott, et al.
The Journal of Infectious Diseases|December 13, 2019
Achieving Elimination as a Public Health Problem for Schistosoma mansoni and S. haematobium: When Is Community-Wide Treatment Required?Jaspreet Toor, David Rollinson, Hugo C Turner, et al.
Parasites & Vectors|September 17, 2019
Determining post-treatment surveillance criteria for predicting the elimination of Schistosoma mansoni transmissionJaspreet Toor, James E Truscott, Marleen Werkman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 1, 2018
Valuing the Unpaid Contribution of Community Health Volunteers to Mass Drug Administration ProgramsHugo C Turner, Jaspreet Toor, Alison A Bettis, et al.
Pageof 4